Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Treasury Shares (2023 - 2025)

CorMedix (CRMD) has disclosed Treasury Shares for 3 consecutive years, with $458220.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 57.2% to $458220.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $458220.0 through Dec 2025, up 57.2% year-over-year, with the annual reading at $458220.0 for FY2025, 57.2% up from the prior year.
  • Treasury Shares hit $458220.0 in Q4 2025 for CorMedix, up from $291494.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $458220.0 in Q4 2025 to a low of $103735.0 in Q3 2023.
  • Historically, Treasury Shares has averaged $284483.0 across 3 years, with a median of $291494.0 in 2024.
  • Biggest YoY gain for Treasury Shares was 57.2% in 2025; the steepest drop was 57.2% in 2025.
  • Year by year, Treasury Shares stood at $103735.0 in 2023, then surged by 181.0% to $291494.0 in 2024, then soared by 57.2% to $458220.0 in 2025.
  • Business Quant data shows Treasury Shares for CRMD at $458220.0 in Q4 2025, $291494.0 in Q4 2024, and $103735.0 in Q3 2023.